Enterogenic™ Intensive 100 is formulated with high-potency probiotics for maximum support of gastrointestinal and immune health.* Enterogenic Intensive 100 provides multiple strains of Lactobacilli and Bifidobacteria per each 100 billion CFU capsule. This high-potency formula and delivery system are designed for maximal support.
Serving Size: 1 Capsule
Servings per Container: 30
|Serving Size: 1 Capsule||Amount/Serving||%DV|
Proprietary Probiotic Blend providing 100 billion CFU:
Lactobacillius casei HA-108; L. paracasei HA- 274; L. acidophilus R0418; L. salivarius HA-118; L. rhamnosus HA-114; L. rhamnosus HA-111
Bifidobacterium breve HA -129; B. bifidum HA-132; B. infantis HA-116; B. longum HA-135
NutraFlora® scFOS (short-chain fructooligosaccharides)
Hydroxypropyl methylcellulose, gellan gum (vegetable capsule), potato starch, magnesium stearate, silicon dioxide, ascorbic acid (preservative to maintain freshness)
Contains milk and soy.
Contains No Added: artificial coloring, artificial flavoring, gluten, wheat
Adults 19+: Take 1 capsule daily. May be taken at any time, with or without food, or as recommended by your healthcare professional. Keep refrigerated to maintain maximum potency. 100 billion CFU potency per capsule is guaranteed until expiration date when bottle is kept tightly closed and refrigerated.
Keep out of reach of children.
If pregnant, nursing, or taking prescription drugs, consult your healthcare professional prior to use.
Side Effect Risks
The information and product descriptions that appear on this website are for information and educational purposes only and are not intended to provide or replace medical advice to individuals from qualified health care professionals. Consult your physician if you have any health concerns, and before initiating any new dietary, exercise, supplements or other lifestyle changes.
1. Minocha A. Nutr Clin Pract 2009;24(2):227–41.
2. Metchnikoff E. Putnam;1908.
3. Goossens D, Jonkers D, Stobberingh E, et al. Scand J Gastroenterol Suppl 2003;15–23.
4. Rolfe RD. J Nutr 2000;130:396S–402S.
5. Isolauri E. Am J Clin Nutr 2001;73:1142S–1146S.
6. Famularo C, Moretti S, Marcellini, De Simone C. Fuller R, ed. Probiotics 2 Applications and
Practical Aspects. London, England: Chapman & Hall; 1997:133–61.
7. Michail SK, Stolfi A, Johnson T, Onady GM. Ann Allergy Asthma Immunol 2008;101:508–16.
8. Zeng J, Li YQ, Zuo XL, et al. Aliment Pharmacol Ther 2008;28:994–1002.
9. Ouwehand AC, Bergsma N, Parhiala R, et al. FEMS Immunol Med Microbiol 2008;53:18–25.
10. Macfarlane GT, Cummings JH. West J Med 1999;171:187–91.
11. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties
of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. October, 2001. Available
[Accessed March 13, 2012.]
12. Fuller R. Introduction. In: Fuller R, ed. Probiotics 2: Applications and Practical Aspects. London,
England: Chapman & Hall; 1997:1–9.
13. Farnworth ER. J Nutr 2008;138: 1250S–54S.
14. Drouault-Holowacz S, Bieuvelet S, Burckel A, et al. Gastroenterol Clin Biol 2008;32:147–52.
15. O’Mahony L, McCarthy J, Kelly P, et al. Gastroenterology 2005;128:541–51.
16. Rerksuppaphol S, Rerksuppaphol L. Ann Trop Paediatr 2010;30(4):299–304.